在胰腺管腺癌中的向和免疫疗法策略:最近的发展和见解

Cheng Xie1, Jian-Ji Ke1, Fei-Qi Liu2

  • 1Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130000, China.

概括

胰腺管道腺癌 (PDAC) 治疗需要改进,因为诊断迟到和化学抵抗. 针对性和免疫疗法显示出希望,特别是在组合中,为更好的PDAC结果提供新的希望.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K